GGrantIndex
← Search

11 Bioinformatics Shared Resource

$370,078P30FY2019CANIH

University Of Tx Md Anderson Can Ctr, Houston TX

Investigators

Linked publications, trials & patents

Trial NCT07407920Trial NCT07349641Trial NCT06651580Trial NCT05681026Trial NCT05223036Trial NCT05078866Trial NCT05057312Trial NCT05054296Trial NCT05044546Trial NCT05023967Trial NCT05011045Trial NCT04875728Trial NCT04870645Trial NCT04810091Trial NCT04751422Trial NCT04740164Trial NCT04668300Trial NCT04615013Trial NCT04505267Trial NCT04484909Trial NCT04483349Trial NCT04481204Trial NCT04474301Trial NCT04458610Trial NCT04447222Trial NCT04435691Trial NCT04430725Trial NCT04407247Trial NCT04373720Trial NCT04317781Trial NCT04311723Trial NCT04310826Trial NCT04310397Trial NCT04265430Trial NCT04257045Trial NCT04256941Trial NCT04239989Trial NCT04239976Trial NCT04239157Trial NCT04236882Trial NCT04228042Trial NCT04220827Trial NCT04220775Trial NCT04220008Trial NCT04219969Trial NCT04219904Trial NCT04216732Trial NCT04216563Trial NCT04216524Trial NCT04216472Trial NCT04215029Trial NCT04200534Trial NCT04199026Trial NCT04196972Trial NCT04189783Trial NCT04189770Trial NCT04189757Trial NCT04188418Trial NCT04188405Trial NCT04186884Trial NCT04186832Trial NCT04185337Trial NCT04181463Trial NCT04171622Trial NCT04171219Trial NCT04171037Trial NCT04169763Trial NCT04169737Trial NCT04169542Trial NCT04160052Trial NCT04151082Trial NCT04150939Trial NCT04140487Trial NCT04135326Trial NCT04134208Trial NCT04132843Trial NCT04132505Trial NCT04132440Trial NCT04129138Trial NCT04128748Trial NCT04128501Trial NCT04127721Trial NCT04125914Trial NCT04119037Trial NCT04106843Trial NCT04106245Trial NCT04090619Trial NCT04090567Trial NCT04087057Trial NCT04083378Trial NCT04082572Trial NCT04074746Trial NCT04066894Trial NCT04062305Trial NCT04062266Trial NCT04058964Trial NCT04054245Trial NCT04054167Trial NCT04054154Trial NCT04053517

Abstract

PROJECT SUMMARY: BIOINFORMATICS SHARED RESOURCE (BISR) The Bioinformatics Shared Resource (BISR) continues to provide cutting-edge support in bioinformatics and computational biology for basic, translational, and clinical research programs throughout MD Anderson. Its personnel include 15 faculty, 15 statistical analysts, 2 bioanalysts, and 10 software engineers, all associated with the Department of Bioinformatics and Computational Biology (DBCB) led by John Weinstein, MD, PhD. DBCB, a leader in bioinformatics nationally and internationally, provides high-quality academic research, education, and computer science as vital ?infrastructure? for the BISR's support function. The BISR analyzes a comprehensive spectrum of bioinformatic data types, including sequences (whole genome, whole exome, RNA-seq, ChIP-seq, ChiRP-seq; bisulfite-seq, ATAC-seq, etc.); DNA, RNA, and protein microarrays; flow cytometry (fluorescence and CyTOF); mass spectrometry (targeted and discovery for proteomics and metabolomics); siRNA, shRNA; CRISPR/Cas9; histopathological and clinical images including CyTOF images; and marker-driven clinical trial data. In addition, BISR faculty and software engineering teams develop professional-grade, user-friendly visualization and analysis software for use at MD Anderson and worldwide. BISR faculty are currently lead principal investigators on 4 NIH U24 grants and an NIH U01 grant for development, application, and sharing of the software. The BISR is proactive in education, both for the next generation of informatics specialists (through the MD Anderson Cancer Center UTHealth Graduate School of Biomedical Sciences, Rice University, and Baylor College of Medicine) and for biologists and clinical researchers who wish to learn elements of data science. Bioinformatics assistance can be requested through 1) the BISR website, 2) weekly walk-in clinics, 3) informal contact, or 4) a DBCB faculty member designated as a liaison for each department or program. As much as possible, BISR analysts and faculty work longitudinally with particular departments and programs to maximize continuity and domain expertise. Over the previous grant cycle, the BISR has supported >900 projects for 355 cancer center members (219 with peer-reviewed funding) in 64 MD Anderson departments, representing all 16 CCSG programs. Included were all 13 MD Anderson Moon Shots plus SPOREs, P01s, and R01s. The most active BISR users were the Head and Neck Cancer (21% total usage), Hematologic Malignancies (15%), and Lung Cancer (11%) CCSG programs. Peer-review funded investigators accounted for 85% of the usage, and 6% ($240,027) of total costs are requested from the CCSG. The BISR has no chargebacks, but users are expected to provide support if their projects are large. BISR faculty averaged 10.3 authorships in 2017, with more than 500 authorships over the 6-year period. BISR staff plus faculty have contributed to 865 papers since the last review: 114 (13%) in journals with IF >20, 273 (32%) in those with IF >10, and 624 (72%) in those with IF >5. The BISR's focus on issues of rigor, reproducibility, accessibility, and interoperability is in tune with FAIR principles and the NIH's new Data Science initiative, in which DBCB is primed to participate.

View original record on NIH RePORTER →